Concord Biotech to hold Non-Deal Roadshow in Mumbai on June 24-25
Concord Biotech officials will meet investors in Mumbai on June 24 and 25, 2026, during a Non-Deal Roadshow organised by Kotak Institutional Equities. Discussions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is shared. The schedule remains subject to changes due to exigencies on the part of the participants or the company.
*this image is generated using AI for illustrative purposes only.
Officials from Concord Biotech will meet investors in Mumbai on June 24 and 25, 2026, during a Non-Deal Roadshow organised by Kotak Institutional Equities. The meetings provide an opportunity for analysts and institutional investors to engage with the company's management. Discussions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is shared.
The regulatory filing was submitted to the exchanges in compliance with Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. The company noted that the schedule remains subject to changes due to exigencies on the part of the participants or the company.
The schedule for the investor meetings is as follows:
| Date & Time | Organised by | Nature of Meeting | Place |
|---|---|---|---|
| 24th & 25th June 2026 10:00 am onwards |
Kotak Institutional Equities |
1x1 / Group Meeting | Mumbai |
Paritosh Trivedi, Company Secretary & Compliance Officer, signed the disclosure on June 19, 2026.
Historical Stock Returns for Concord Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.40% | -2.10% | +16.88% | -2.14% | -34.54% | +39.49% |
What key strategic priorities is Concord Biotech likely to emphasize during the roadshow?
How might investor sentiment shift following the management's engagement with institutional investors?
What potential market reactions could arise from the discussions, despite the restriction on sharing unpublished price-sensitive information?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
